Brad Prechtl was named CEO of Florida Cancer Specialists & Research Institute in 2009.
FORT MYERS — Florida Cancer Specialists CEO Brad Precthl is retiring from the statewide community oncology practice after more than a decade at the helm of the organization.
Precthl’s retirement is effective July 30, according to a statement, and he will remain with the organization as a consultant through April 2021. The organization’s CFO, Nathan Walcker, has been named CEO effective Aug. 1, the release adds.
Prechtl was named CEO of FCS in 2009, coming to the organization from Physician Oncology Services, a prostate cancer treatment network in Georgia and Indiana, where he was COO. Prechtl led FCS on a major growth spurt, helping to create the “infrastructure that enabled the company to become a nationally recognized community oncology practice leader,” the release states. FCS expanded its clinical sites under Precthl’s leadership, and also added imaging, specialty pharmacy, care management, pathology services and clinical trials/research.
FCS, with more than 230 physicians, 220 advanced practice registered nurses and physician assistants and some 100 locations statewide, is also now one of the biggest oncology practices in Florida. It did $2.1 billion in revenue and collections in 2017, the last year it disclosed revenue. That was up 14.75% from $1.83 billion in 2016.
“I am deeply honored to have had the opportunity to steer such an innovative organization over the last 10-plus years,” Prechtl says in the release. “FCS has developed and grown with the singular goal of consistently providing the highest quality of value-based cancer care. I am very proud of all that we’ve accomplished and have been inspired every day by the dedication and commitment of my colleagues, physicians, clinicians and employees, and the courage and perseverance of our patients.”
Walcker joined FCS in August, bringing more than a decade of health care, physician services and corporate finance expertise, the release states. “Nate’s passion for our mission and commitment to our patients, team members and physicians is apparent,” FCS President and Managing Physician Dr. Lucio Gordan says in the statement. “The Executive Board and I are confident that his vision for the future, coupled with the clinical expertise and long-standing reputation of our physicians and providers, positions us well as an organization.”
Walcker, after earning a degree in Economics from Columbia University, started his career on the trading floor at Merrill Lynch in New York City. He later earned an M.B.A. from Columbia Business School, and then held senior positions as an investment banker focused on M&A and strategic advisory for health care clients worldwide.
“Florida Cancer Specialists is a really special organization doing great things for patients within local communities across the state," Walcker says in the release. "I look forward to building on the solid foundation that materialized under Brad’s leadership and driving FCS forward into its next chapter.”